Finasteride in the treatment of female pattern (androgenic) alopecia: a case report and review of the literature.

Olga Boychenko, Robert M Bernstein, Eric S Schweiger

Case Report Cutis 2012

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D22988650'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Abstract

We describe a case of a 44-year-old woman with biopsy-proven female androgenic alopecia (FAGA), or female pattern alopecia, who was nonresponsive to topical minoxidil. After careful consideration and discussion with the patient, the decision was made to introduce oral finasteride 1.25 mg daily. After only 3.5 months of therapy there was a remarkable reduction in hair shedding and increased hair regrowth without any reported side effects. We also present a comprehensive review of the limited studies and case series that have reported finasteride use for FAGA.

Used In Evidence Reviews

A Finasteride per Alopecia androgenetica

A Minoxidil per Alopecia androgenetica

Finasteride in the treatment of female pattern (androgenic) alopecia: a case report and review of the literature.

Embed This Widget

Abstract

Used In Evidence Reviews

Similar Papers

Secular trends in dietary intake in the United States.

Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.

Androgenetic alopecia: a review.

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.

The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.

Alopecia areata.